Sanofi's nirsevimab shows positive topline results in RSV Phase 2/3 MEDLEY trial
28 June 2021 - 8:33PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Apr 2024 to May 2024
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From May 2023 to May 2024